This live program explores key clinical practice insights for patients with advanced cutaneous squamous cell carcinoma.

Answers in CME · Live Program

Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma

The role of neoadjuvant immunotherapy in the treatment plan for surgically resectable disease.

CSCCImmunotherapyNeoadjuvantCME

FacultyDavid M. Miller
Vishal A. Patel

DateMarch 19, 2023

ProgramAnswers in CME

FormatLive CME program

Event

Answers in CME

View program page →

Overview

In this live program we discuss how neoadjuvant immunotherapy fits into the treatment plan for many patients with surgically resectable cutaneous squamous cell carcinoma.

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement.